ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Authors:
- Alzheimer’s Disease Neuroimaging InitiativeAIAlzheimer’s Disease Neuroimaging Initiative
- Shane Antony LiddelowSLShane Antony Liddelow
Top Cited Papers
- 20 September 2017
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 549 (7673) , 523-527
Abstract
ApoE4 exacerbates tau pathogenesis, neuroinflammation and tau-mediated neurodegeneration independently of brain amyloid-β pathology, and exerts a ‘toxic’ gain of function whereas its absence is protective. APOE4 is the strongest genetic risk factor for late-onset Alzheimer disease. ApoE4 increases brain amyloid-β pathology compared to other ApoE isoforms. However, whether APOE independently influences tau pathology is not clear. David Holtzman and colleagues now show that ApoE4 exacerbates tau pathogenesis, neuroinflammation, and tau-mediated neurodegeneration independent of amyloid-β pathology. ApoE4 exerts a 'toxic' gain of function, whereas the absence of ApoE is protective. APOE4 is the strongest genetic risk factor for late-onset Alzheimer disease. ApoE4 increases brain amyloid-β pathology relative to other ApoE isoforms1. However, whether APOE independently influences tau pathology, the other major proteinopathy of Alzheimer disease and other tauopathies, or tau-mediated neurodegeneration, is not clear. By generating P301S tau transgenic mice on either a human ApoE knock-in (KI) or ApoE knockout (KO) background, here we show that P301S/E4 mice have significantly higher tau levels in the brain and a greater extent of somatodendritic tau redistribution by three months of age compared with P301S/E2, P301S/E3, and P301S/EKO mice. By nine months of age, P301S mice with different ApoE genotypes display distinct phosphorylated tau protein (p-tau) staining patterns. P301S/E4 mice develop markedly more brain atrophy and neuroinflammation than P301S/E2 and P301S/E3 mice, whereas P301S/EKO mice are largely protected from these changes. In vitro, E4-expressing microglia exhibit higher innate immune reactivity after lipopolysaccharide treatment. Co-culturing P301S tau-expressing neurons with E4-expressing mixed glia results in a significantly higher level of tumour-necrosis factor-α (TNF-α) secretion and markedly reduced neuronal viability compared with neuron/E2 and neuron/E3 co-cultures. Neurons co-cultured with EKO glia showed the greatest viability with the lowest level of secreted TNF-α. Treatment of P301S neurons with recombinant ApoE (E2, E3, E4) also leads to some neuronal damage and death compared with the absence of ApoE, with ApoE4 exacerbating the effect. In individuals with a sporadic primary tauopathy, the presence of an ε4 allele is associated with more severe regional neurodegeneration. In individuals who are positive for amyloid-β pathology with symptomatic Alzheimer disease who usually have tau pathology, ε4-carriers demonstrate greater rates of disease progression. Our results demonstrate that ApoE affects tau pathogenesis, neuroinflammation, and tau-mediated neurodegeneration independently of amyloid-β pathology. ApoE4 exerts a ‘toxic’ gain of function whereas the absence of ApoE is protective.Keywords
This publication has 29 references indexed in Scilit:
- Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiersActa Neuropathologica, 2017
- Inflammasome-activated gasdermin D causes pyroptosis by forming membrane poresNature, 2016
- TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal DystrophyNeuron, 2016
- Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 miceAnnals of Neurology, 2014
- APOε4 is associated with enhanced in vivo innate immune responses in human subjectsJournal of Allergy and Clinical Immunology, 2014
- Argyrophilic grain disease differs from other tauopathies by lacking tau acetylationActa Neuropathologica, 2013
- Genomic Analysis of Reactive AstrogliosisThe Journal of Neuroscience, 2012
- Apolipoprotein E ε4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementiaProceedings of the National Academy of Sciences, 2009
- Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.Proceedings of the National Academy of Sciences, 1994
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993